CD47 deficiency protects mice from diet-induced obesity and improves whole body glucose tolerance and insulin sensitivity

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Maimaitiyiming, Hasiyeti ^a   Norman, Heather ^a   Zhou, Qi ^a   Wang, Shuxia ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; CD47 PROTEIN, MOUSE; FAT INTAKE; GLUCOSE BLOOD LEVEL; THROMBOSPONDIN 1; THROMBOSPONDIN-1, MOUSE;

ADVERSE EFFECTS; ANIMAL; FAT INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; MOUSE; OBESITY;

ANIMALS; ANTIGENS, CD47; BLOOD GLUCOSE; DIETARY FATS; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MICE; OBESITY; THROMBOSPONDIN 1;

EID: 84924390135     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08846     Document Type: Article

References (51)

1. Inoue, M. et al. Thrombospondin 1mediates high-fat diet-induced muscle fibrosis and insulin resistance in male mice. Endocrinology 154, 4548-4559, doi 10.1210/en.2013-1587 2013).
2. Varma, V. et al. Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes 57, 432-439 2008).
3. Li, Y., Tong, X., Rumala, C., Clemons, K. & Wang, S. Thrombospondin1 deficiency reduces obesity-associated inflammation and improves insulin sensitivity in a diet-induced obese mouse model. PLoS One 6, e26656 2011).
4. Kong, P. et al. Thrombospondin-1 regulates adiposity and metabolic dysfunction in diet-induced obesity enhancing adipose inflammation and stimulating adipocyte proliferation. Am J Physiol Endocrinol Metab 305, E439-450 2013).
5. Mikhailenko, I. et al. Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain HBD).High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein. J Biol Chem 272, 6784-6791 1997).
6. Goicoechea, S., Orr, A. W., Pallero, M. A., Eggleton, P. & Murphy-Ullrich, J. E. Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin. J Biol Chem 275, 36358-36368 2000).
7. Chandrasekaran, L. et al. Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1. Mol Biol Cell 11, 2885-2900 2000).
8. Jimenez, B. et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6, 41-48 2000).
9. Frazier, W. A. et al. The thrombospondin receptor integrin-associated protein CD47) functionally couples to heterotrimeric Gi. J Biol Chem 274, 8554-8560 1999).
10. Wang, S. et al. Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans. J Cell Biochem 91, 766-776 2004).
11. Bornstein, P. Thrombospondins as matricellular modulators of cell function. J Clin Invest 107, 929-934 2001).
12. Murphy-Ullrich, J. E. & Mosher, D. F. Interactions of thrombospondin with endothelial cells receptor-mediated binding and degradation. J Cell Biol 105, 1603-1611 1987).
13. Taraboletti, G., Roberts, D. D. & Liotta, L. A. Thrombospondin-induced tumor cell migration haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol 105, 2409-2415 1987).
14. Lawler, J., Weinstein, R. & Hynes, R. O. Cell attachment to thrombospondin the role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol 107, 2351-2361 1988).
15. Gao, A. G. et al. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 271, 21-24 1996).
16. Carlson, C. B., Lawler, J. &Mosher, D. F. Structures of thrombospondins. Cell Mol Life Sci 65, 672-686 2008).
17. Matozaki, T., Murata, Y., Okazawa, H. & Ohnishi, H. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Trends Cell Biol 19, 72-80, doi 10.1016/j.tcb.2008.12.001 2009).
18. Oldenborg, P. A. CD47 A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease. ISRN Hematol 2013, 614619, doi 10.1155/2013/614619 2013).
19. Brown, E. J. & Frazier, W. A. Integrin-associated protein CD47) and its ligands. Trends Cell Biol 11, 130-135 2001).
20. Barclay, A. N. & Van den Berg, T. K. The Interaction Between Signal Regulatory Protein Alpha SIRPalpha) and CD47 Structure, Function, and Therapeutic Target. Annu Rev Immunol 32, 25-50, doi 10.1146/annurev-immunol-032713-120142 2014).
21. Rogers, N. M. et al. Activated CD47 regulates multiple vascular and stress responses implications for acute kidney injury and its management. Am J Physiol Renal Physiol 303, F1117-1125, doi 10.1152/ajprenal.00359.2012 2012).
22. Isenberg, J. S. et al. Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress. Matrix Biol 28, 110-119, doi 10.1016/j.matbio.2009.01.002 2009).
23. Isenberg, J. S., Shiva, S. & Gladwin, M. Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation. Nitric Oxide 21, 52-62 2009).
24. Isenberg, J. S., Frazier, W. A., Krishna, M. C., Wink, D. A. & Roberts, D. D. Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling. Curr Drug Targets 9, 833-841 2008).
25. Isenberg, J. S. et al. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 281, 26069-26080 2006).
26. Yao, M., Roberts, D. D. & Isenberg, J. S. Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP. Pharmacol Res 63, 13-22, doi 10.1016/j.phrs.2010.10.014 2011).
27. Ramanathan, S., Mazzalupo, S., Boitano, S.&Montfort, W. R. Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration. Biochemistry 50, 7787-7799, doi 10.1021/bi201060c 2011).
28. Wajchenberg, B. L. Subcutaneous and visceral adipose tissue their relation to the metabolic syndrome. Endocr Rev 21, 697-738, doi 10.1210/edrv.21.6.0415 2000).
29. Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808 2003).
30. Koppaka, S. et al. Reduced adipose tissue macrophage content is associated with improved insulin sensitivity in thiazolidinedione-treated diabetic humans. Diabetes 62, 1843-1854 2013).
31. Xu,H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821-1830 2003).
32. Frazier, E. P. et al. Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47. Matrix Biol 30, 154-161, doi 10.1016/j.matbio.2010.12.004 2011).
33. Cannon, B. & Nedergaard, J. Brown adipose tissue function and physiological significance. Physiol Rev 84, 277-359 2004).
34. Cannon, B.&Nedergaard, J. Metabolic consequences of the presence or absence of the thermogenic capacity of brown adipose tissue in mice and probably in humans). Int J Obes Lond) 34 Suppl 1, S7-16, doi 10.1038/ijo.2010.177 2010).
35. Richard, D. & Picard, F. Brown fat biology and thermogenesis. Frontiers in bioscience Landmark edition) 16, 1233-1260 2011).
36. Schreurs, M., Kuipers, F. & van der Leij, F. R. Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome. Obesity reviews an official journal of the International Association for the Study of Obesity 11, 380-388, doi 10.1111/j.1467-789X.2009.00642.x 2010).
37. Handa, P. et al. Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding. Arterioscler Thromb Vasc Biol 31, 2827-2835, doi 10.1161/atvbaha.111.236554 2011).
38. Rizzo, N. O. et al. Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding. Arterioscler Thromb Vasc Biol 30, 758-765, doi 10.1161/atvbaha.109.199893 2010).
39. Sick, E. et al. CD47 update amultifaceted actor in the tumour microenvironment of potential therapeutic interest. Br J Pharmacol 167, 1415-1430, doi 10.1111/j.1476-5381.2012.02099.x 2012).
40. Willingham, S. B. et al. The CD47-signal regulatory protein alpha SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci USA 109, 6662-6667, doi 10.1073/pnas.1121623109 2012).
41. Soto-Pantoja, D. R., Isenberg, J. S. & Roberts, D. D. Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and Radiation. J Genet Syndr Gene Ther 2 2011).
42. Maxhimer, J. B., Shih, H. B., Isenberg, J. S., Miller, T. W. & Roberts, D. D. Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective. Plast Reconstr Surg 124, 1880-1889, doi 10.1097/PRS.0b013e3181bceec3 2009).
43. Kanda, H. et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116, 1494-1505 2006).
44. Weisberg, S. P. et al. CCR2 modulates inflammatory and metabolic effects of highfat feeding. J Clin Invest 116, 115-124 2006).
45. Kamei, N. et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281, 26602-26614 2006).
46. Sullivan, T. J. et al. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes. Metabolism 62, 1623-1632 2013).
47. Gutierrez, D. A. et al. Aberrant accumulation of undifferentiated myeloid cells in the adipose tissue of CCR2-deficient mice delays improvements in insulin sensitivity. Diabetes 60, 2820-2829 2011).
48. Oh, D. Y., Morinaga, H., Talukdar, S., Bae, E. J. & Olefsky, J. M. Increased macrophage migration into adipose tissue in obese mice. Diabetes 61, 346-354 2012).
49. Haas, B. et al. Protein kinase G controls brown fat cell differentiation and mitochondrial biogenesis. Science signaling 2, ra78, doi 10.1126/scisignal.2000511 2009).
50. Mitschke, M. M. et al. Increased cGMP promotes healthy expansion and browning of white adipose tissue. Faseb j 27, 1621-1630, doi 10.1096/fj.12-221580 2013).
51. Nikolic, D. M., Li, Y., Liu, S. & Wang, S. Overexpression of constitutively active PKG-I protects female, but not male mice from diet-induced obesity. Obesity Silver Spring) 19, 784-791, doi 10.1038/oby.2010.223 2011).